Found: 18
Select item for more details and to access through your institution.
Up Front.
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1757, doi. 10.1007/s00125-023-06000-8
- Publication type:
- Article
Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy.
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1832, doi. 10.1007/s00125-023-05988-3
- By:
- Publication type:
- Article
Incretins: turning the venom into the antidote.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Daniel Porte Jr, 13 August 1931–13 May 2023.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Incretins beyond type 2 diabetes.
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1809, doi. 10.1007/s00125-023-05980-x
- By:
- Publication type:
- Article
SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study.
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1869, doi. 10.1007/s00125-023-05975-8
- By:
- Publication type:
- Article
Incretins and cardiovascular disease: to the heart of type 2 diabetes?
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1820, doi. 10.1007/s00125-023-05973-w
- By:
- Publication type:
- Article
Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort study.
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1908, doi. 10.1007/s00125-023-05971-y
- By:
- Publication type:
- Article
Socioeconomic aspects of incretin-based therapy.
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1859, doi. 10.1007/s00125-023-05962-z
- By:
- Publication type:
- Article
Hyperglucagonaemia in diabetes: altered amino acid metabolism triggers mTORC1 activation, which drives glucagon production.
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1925, doi. 10.1007/s00125-023-05967-8
- By:
- Publication type:
- Article
The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease.
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1846, doi. 10.1007/s00125-023-05966-9
- By:
- Publication type:
- Article
Reversal of dual epigenetic repression of non-canonical Wnt-5a normalises diabetic corneal epithelial wound healing and stem cells.
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1943, doi. 10.1007/s00125-023-05960-1
- By:
- Publication type:
- Article
Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial.
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1882, doi. 10.1007/s00125-023-05968-7
- By:
- Publication type:
- Article
Strength training is more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes: a randomised controlled trial.
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1897, doi. 10.1007/s00125-023-05958-9
- By:
- Publication type:
- Article
Incretin hormones and type 2 diabetes.
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1780, doi. 10.1007/s00125-023-05956-x
- By:
- Publication type:
- Article
Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy.
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1796, doi. 10.1007/s00125-023-05929-0
- By:
- Publication type:
- Article
The expanding incretin universe: from basic biology to clinical translation.
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1765, doi. 10.1007/s00125-023-05906-7
- By:
- Publication type:
- Article
Genetic associations vary across the spectrum of fasting serum insulin: results from the European IDEFICS/I.Family children's cohort.
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1914, doi. 10.1007/s00125-023-05957-w
- By:
- Publication type:
- Article